MetLife, Inc. (NYSE:MET - Get Free Report) was the recipient of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 6,420,000 shares, a decrease of 12.8% from the February 28th total of 7,360,000 shares. Approximately 1.1% of the company's stock are short sold. Based on an average daily trading volume, of 3,470,000 shares, the short-interest ratio is presently 1.9 days.
Institutional Investors Weigh In On MetLife
Institutional investors have recently made changes to their positions in the stock. Ball & Co Wealth Management Inc. acquired a new stake in shares of MetLife in the fourth quarter valued at about $25,000. Transce3nd LLC acquired a new stake in shares of MetLife during the 4th quarter valued at approximately $26,000. Quarry LP purchased a new stake in shares of MetLife during the 4th quarter worth approximately $31,000. Retirement Wealth Solutions LLC acquired a new stake in shares of MetLife in the 4th quarter worth approximately $32,000. Finally, Sierra Ocean LLC purchased a new position in MetLife in the 4th quarter valued at approximately $32,000. 94.99% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of brokerages have issued reports on MET. Wells Fargo & Company lifted their price target on MetLife from $92.00 to $97.00 and gave the stock an "overweight" rating in a report on Wednesday, February 19th. UBS Group boosted their price objective on shares of MetLife from $94.00 to $98.00 and gave the stock a "buy" rating in a research report on Wednesday. Morgan Stanley increased their target price on shares of MetLife from $101.00 to $109.00 and gave the company an "overweight" rating in a research report on Friday, February 28th. Cowen reissued a "buy" rating on shares of MetLife in a research report on Friday, March 7th. Finally, JPMorgan Chase & Co. cut their price target on MetLife from $88.00 to $86.00 and set an "overweight" rating on the stock in a research report on Wednesday. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $94.85.
Read Our Latest Research Report on MET
MetLife Stock Performance
Shares of MetLife stock traded down $6.69 on Thursday, reaching $75.80. 6,197,321 shares of the stock were exchanged, compared to its average volume of 3,303,445. The firm has a market capitalization of $51.64 billion, a PE ratio of 12.70, a PEG ratio of 0.65 and a beta of 1.04. MetLife has a 1-year low of $67.30 and a 1-year high of $89.05. The business has a fifty day moving average price of $82.98 and a two-hundred day moving average price of $83.01. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54.
MetLife (NYSE:MET - Get Free Report) last released its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. As a group, research analysts anticipate that MetLife will post 9.65 earnings per share for the current fiscal year.
MetLife Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th were given a $0.545 dividend. This represents a $2.18 annualized dividend and a yield of 2.88%. The ex-dividend date was Tuesday, February 4th. MetLife's payout ratio is 36.52%.
About MetLife
(
Get Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.